Close

Leerink Swann Upgrades Luminex (LMNX) to Outperform Following EraGen Acquisition

June 22, 2011 8:00 AM EDT
Get Alerts LMNX Hot Sheet
Price: $36.99 --0%

Rating Summary:
    1 Buy, 9 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 11 | Down: 12 | New: 9
Join SI Premium – FREE
Leerink Swann upgraded Luminex (NASDAQ: LMNX) from Market Perform
to Outperform. Valuation increased to $23-$25 (from $20-$22)

Leerink analyst says, "We view LMNX's announced acquisition of EraGen Biosciences favorably and believe EraGen not only expands LMNX's revenue base but also its opportunity set. The deal offers an opportunity for meaningful value creation if managed properly, and we believe investors will come to increasingly appreciate this value over time."

For more ratings news on Luminex click here and for the rating history of Luminex click here.

Shares of Luminex closed at $19.64 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades